Today: 6 January 2026
Subscribe
Browse Category

IPO Updates News 8 December 2025 - 23 December 2025

7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

DALLAS / TOKYO — December 22, 2025 — 7‑Eleven’s North American business is heading into a major leadership transition just as its Japanese parent, Seven & i Holdings, accelerates a broader turnaround and prepares the groundwork for a future U.S.
22 December 2025
····
Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock MDLN Stock News and Forecast: Shares Surge After 2025’s Biggest IPO as Debt and Tariff Risks Take Center Stage

Medline Inc. Class A Common Stock—trading on the Nasdaq Global Select Market under the ticker MDLN—is having the kind of debut that makes IPO bankers briefly believe in destiny again. On Wednesday, December 17, 2025, Medline shares opened at $35
18 December 2025
····
Park Medi World IPO Listing 17 December 2025: Shares Debut at Discount on BSE, NSE Despite Strong Subscription — Key Numbers, GMP Signals, and Allotment Check Steps

Park Medi World IPO Listing 17 December 2025: Shares Debut at Discount on BSE, NSE Despite Strong Subscription — Key Numbers, GMP Signals, and Allotment Check Steps

Park Medi World’s much-watched IPO debut delivered a reality check for investors on Wednesday, 17 December 2025, as the hospital-chain operator’s shares listed below the IPO issue price on both major Indian exchanges—despite the offer being subscribed over eight times
17 December 2025
···
Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

New Delhi / Mumbai, December 15, 2025 — Corona Remedies Limited, the Ahmedabad-headquartered branded pharmaceutical formulations company (not the beer), hit Dalal Street with a headline-worthy debut on Monday: the stock listed at a 38%+ premium to its IPO price,
15 December 2025
····
Meesho Limited Share Price Today (14 Dec 2025): IPO Stock Cools After Blockbuster Debut, Latest News, Targets, and Week-Ahead Outlook

Meesho Limited Share Price Today (14 Dec 2025): IPO Stock Cools After Blockbuster Debut, Latest News, Targets, and Week-Ahead Outlook

Updated: Sunday, 14 December 2025 (Indian markets are closed today; the latest official traded close is from Friday, 12 December 2025.) SEO meta description: Meesho Limited stock (NSE: MEESHO, BSE: 544632) after its IPO debut—this week’s price action, latest news,
14 December 2025
····
UltraGreen.ai Limited Stock (SGX: ULG) Update: Price Stabilisation Ends, Insider Buying Rises, and a US$2 Target Puts the Post‑IPO Story Back in Focus

UltraGreen.ai Limited Stock (SGX: ULG) Update: Price Stabilisation Ends, Insider Buying Rises, and a US$2 Target Puts the Post‑IPO Story Back in Focus

SINGAPORE — 13 December 2025 — UltraGreen.ai Limited stock is back on investors’ radar this weekend after two market-moving developments landed within 24 hours: insider buying by a well-known independent director and confirmation that post‑IPO share price stabilisation has been
13 December 2025
····
Reliance Industries Share Price Today, 10 December 2025: RIL Near Record High as S&P Upgrade, Jio IPO Plans and ‘Fourth Monetisation Wave’ Lift Outlook

Reliance Industries Share Price Today, 10 December 2025: RIL Near Record High as S&P Upgrade, Jio IPO Plans and ‘Fourth Monetisation Wave’ Lift Outlook

Mumbai | 10 December 2025 Reliance Industries Ltd (RIL) shares were trading higher on Wednesday, extending a powerful year‑to‑date rally as a fresh S&P Global Ratings upgrade, strong Q2 FY26 earnings and visible progress on the long‑awaited Jio Platforms IPO
10 December 2025
····
1 2
Go toTop